Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Lateral Internal Sphincterotomy in Chronic Anal Fissure
NCT07568314Completed
- Sponsor
- Islamabad Medical and Dental College
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in chronic anal fissure (CAF) (2 arms), sponsored by Islamabad Medical and Dental College. Primary endpoint: Proportion of patients with complete fissure healing at 3 months. Started Mar 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NCT07568314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568314.